
Kevin S. Orwig
Examiner (ID: 6462, Phone: (571)270-5869 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611, 3991, 1658 |
| Total Applications | 903 |
| Issued Applications | 255 |
| Pending Applications | 44 |
| Abandoned Applications | 609 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15405429
[patent_doc_number] => 20200023036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-23
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY RESPIRATORY DISEASE CONTAINING FUSION PROTEIN IN WHICH CELL-PENETRATING PEPTIDE AND CTCTLA4 PEPTIDE ARE FUSED AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/485706
[patent_app_country] => US
[patent_app_date] => 2018-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8285
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485706
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485706 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY RESPIRATORY DISEASE CONTAINING FUSION PROTEIN IN WHICH CELL-PENETRATING PEPTIDE AND CTCTLA4 PEPTIDE ARE FUSED AS ACTIVE INGREDIENT | Mar 26, 2018 | Abandoned |
Array
(
[id] => 13729533
[patent_doc_number] => 20180369234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/928957
[patent_app_country] => US
[patent_app_date] => 2018-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10286
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15928957
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/928957 | MULTIDIRECTIONAL MUCOSAL DELIVERY DEVICES AND METHODS OF USE | Mar 21, 2018 | Abandoned |
Array
(
[id] => 13440499
[patent_doc_number] => 20180271792
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ORAL DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCES
[patent_app_type] => utility
[patent_app_number] => 15/922651
[patent_app_country] => US
[patent_app_date] => 2018-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15922651
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/922651 | ORAL DELIVERY OF PHYSIOLOGICALLY ACTIVE SUBSTANCES | Mar 14, 2018 | Abandoned |
Array
(
[id] => 12904474
[patent_doc_number] => 20180193333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-12
[patent_title] => TRANSDERMAL DELIVERY SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/915369
[patent_app_country] => US
[patent_app_date] => 2018-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36627
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 151
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15915369
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/915369 | TRANSDERMAL DELIVERY SYSTEM | Mar 7, 2018 | Abandoned |
Array
(
[id] => 12880975
[patent_doc_number] => 20180185500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-05
[patent_title] => FUNCTIONALIZED NANOMATERIALS
[patent_app_type] => utility
[patent_app_number] => 15/914694
[patent_app_country] => US
[patent_app_date] => 2018-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4981
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 53
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15914694
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/914694 | Nanoparticles functionalized with sulfur-containing polymers | Mar 6, 2018 | Issued |
Array
(
[id] => 12857833
[patent_doc_number] => 20180177785
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => Method of Making Sustained Release Microparticles
[patent_app_type] => utility
[patent_app_number] => 15/903853
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15903853
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/903853 | Method of Making Sustained Release Microparticles | Feb 22, 2018 | Abandoned |
Array
(
[id] => 17405959
[patent_doc_number] => 11246818
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-15
[patent_title] => Peptides and compositions for use in cosmetics
[patent_app_type] => utility
[patent_app_number] => 16/485310
[patent_app_country] => US
[patent_app_date] => 2018-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 29
[patent_no_of_words] => 15849
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16485310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/485310 | Peptides and compositions for use in cosmetics | Feb 22, 2018 | Issued |
Array
(
[id] => 15239729
[patent_doc_number] => 20190374650
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-12
[patent_title] => COMPOSITIONS AND METHODS FOR DELIVERY OF POLYMER/BIOMACROMOLECULE CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/488031
[patent_app_country] => US
[patent_app_date] => 2018-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32287
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16488031
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/488031 | COMPOSITIONS AND METHODS FOR DELIVERY OF POLYMER/BIOMACROMOLECULE CONJUGATES | Feb 20, 2018 | Abandoned |
Array
(
[id] => 14609783
[patent_doc_number] => 10357570
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron
[patent_app_type] => utility
[patent_app_number] => 15/897093
[patent_app_country] => US
[patent_app_date] => 2018-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10603
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 118
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15897093
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/897093 | Methods of treating nausea utilizing semi-solid delivery vehicle compositions comprising granisetron | Feb 13, 2018 | Issued |
Array
(
[id] => 15945965
[patent_doc_number] => 10660860
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-05-26
[patent_title] => Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof
[patent_app_type] => utility
[patent_app_number] => 15/892140
[patent_app_country] => US
[patent_app_date] => 2018-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 68
[patent_figures_cnt] => 132
[patent_no_of_words] => 20496
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15892140
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/892140 | Therapeutic cationic peptides and unimolecular nanoparticles for efficient delivery thereof | Feb 7, 2018 | Issued |
Array
(
[id] => 16555824
[patent_doc_number] => 20210000972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/602046
[patent_app_country] => US
[patent_app_date] => 2018-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16602046
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/602046 | NANOPARTICLES FOR SUSTAINED OPHTHALMIC DRUG DELIVERY AND METHODS OF USE | Jan 24, 2018 | Abandoned |
Array
(
[id] => 12857908
[patent_doc_number] => 20180177810
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-28
[patent_title] => MULTIFUNCTIONAL MICELLAR NANOPARTICLE-BASED DRUG AND TARGETING AGENT SYSTEM
[patent_app_type] => utility
[patent_app_number] => 15/878295
[patent_app_country] => US
[patent_app_date] => 2018-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13066
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15878295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/878295 | MULTIFUNCTIONAL MICELLAR NANOPARTICLE-BASED DRUG AND TARGETING AGENT SYSTEM | Jan 22, 2018 | Abandoned |
Array
(
[id] => 14990663
[patent_doc_number] => 20190314289
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse
[patent_app_type] => utility
[patent_app_number] => 15/876589
[patent_app_country] => US
[patent_app_date] => 2018-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21570
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -66
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15876589
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/876589 | Pharmaceutical Compositions for the Deterrence and/or Prevention of Abuse | Jan 21, 2018 | Abandoned |
Array
(
[id] => 17695875
[patent_doc_number] => 11369576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-28
[patent_title] => Transdermal patch with separated regions for delivery of immunomodulators
[patent_app_type] => utility
[patent_app_number] => 15/865001
[patent_app_country] => US
[patent_app_date] => 2018-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 57
[patent_no_of_words] => 22194
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 408
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15865001
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/865001 | Transdermal patch with separated regions for delivery of immunomodulators | Jan 7, 2018 | Issued |
Array
(
[id] => 14596823
[patent_doc_number] => 10351594
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-16
[patent_title] => Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging
[patent_app_type] => utility
[patent_app_number] => 15/861300
[patent_app_country] => US
[patent_app_date] => 2018-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 9
[patent_no_of_words] => 18249
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15861300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/861300 | Process for preparing compounds having triple activities of thrombolysis, antithrombosis, and radical scavenging | Jan 2, 2018 | Issued |
Array
(
[id] => 12675676
[patent_doc_number] => 20180117058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-05-03
[patent_title] => SKIN-PENETRATING FORMULATION OF TAUROLIDINE
[patent_app_type] => utility
[patent_app_number] => 15/858228
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15858228
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/858228 | SKIN-PENETRATING FORMULATION OF TAUROLIDINE | Dec 28, 2017 | Abandoned |
Array
(
[id] => 15766045
[patent_doc_number] => 20200114040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => ANTIMICROBIAL WOUND DRESSINGS
[patent_app_type] => utility
[patent_app_number] => 16/472144
[patent_app_country] => US
[patent_app_date] => 2017-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6358
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16472144
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/472144 | ANTIMICROBIAL WOUND DRESSINGS | Dec 27, 2017 | Abandoned |
Array
(
[id] => 16175540
[patent_doc_number] => 20200222508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-07-16
[patent_title] => GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 16/471596
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471596
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471596 | GLUCAGON-LIKE PEPTIDE 1 (GLP-1) RECEPTOR AGONIST COMPOSITIONS | Dec 21, 2017 | Abandoned |
Array
(
[id] => 13440617
[patent_doc_number] => 20180271851
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ASSAYS, METHODS AND MEANS
[patent_app_type] => utility
[patent_app_number] => 15/853174
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853174
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853174 | ASSAYS, METHODS AND MEANS | Dec 21, 2017 | Abandoned |
Array
(
[id] => 13440615
[patent_doc_number] => 20180271850
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-27
[patent_title] => ASSAYS, METHODS AND MEANS
[patent_app_type] => utility
[patent_app_number] => 15/853103
[patent_app_country] => US
[patent_app_date] => 2017-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53664
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15853103
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/853103 | ASSAYS, METHODS AND MEANS | Dec 21, 2017 | Abandoned |